Home > Balance Sheet > INDO US BIOTECH

INDO US BIOTECH
Net Current Assets

    Back to Balance Sheet
AD     Remove this Ad

INDO US BIOTECH Last 5 Year Net Current Assets History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹70 Cr₹56 Cr₹48 Cr₹35 Cr₹20 Cr

What is the latest Net Current Assets ratio of INDO US BIOTECH ?

The latest Net Current Assets ratio of INDO US BIOTECH is ₹70 Cr based on Mar2025 Standalone results.
Year Net Current Assets
Mar2025₹70 Cr
Mar2024₹56 Cr
Mar2023₹48 Cr
Mar2022₹35 Cr
Mar2021₹20 Cr

How is Net Current Assets of INDO US BIOTECH Trending?

Years Net Current Assets % Change
Mar2025 ₹70 Cr
26.54
Mar2024 ₹56 Cr
16.82
Mar2023 ₹48 Cr
36.64
Mar2022 ₹35 Cr
72.77
Mar2021 ₹20 Cr -

Compare Net Current Assets of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹282.2 Cr -6.7% 6.9% -35% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,047.9 Cr -2.7% 0.8% -7% Stock Analytics
KAVERI SEED COMPANY ₹4,107.4 Cr -1.7% -7.4% -20.7% Stock Analytics
VENKYS (INDIA) ₹1,910.0 Cr -1.5% -10.6% -18.3% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹931.3 Cr -3.7% -1.7% -36% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹362.5 Cr -5.6% -13.7% -20.2% Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

-6.7%

6.9%

-35%

SENSEX

-0.3%

-0.1%

8.3%


You may also like the below Video Courses